PGC-1α, mitochondrial dysfunction, and Huntington's disease
- PMID: 23602910
- PMCID: PMC3722269
- DOI: 10.1016/j.freeradbiomed.2013.04.016
PGC-1α, mitochondrial dysfunction, and Huntington's disease
Abstract
The constant high energy demand of neurons makes them rely heavily on their mitochondria. Dysfunction of mitochondrial energy metabolism leads to reduced ATP production, impaired calcium buffering, and generation of reactive oxygen species. There is strong evidence that mitochondrial dysfunction results in neurodegeneration and may contribute to the pathogenesis of Huntington's disease (HD). Studies over the past few years have implicated an impaired function of peroxisome proliferator-activated receptor (PPAR)-γ coactivator-1α (PGC-1α), a transcriptional master coregulator of mitochondrial biogenesis, metabolism, and antioxidant defenses, in causing mitochondrial dysfunction in HD. Here we have attempted to discuss in a nutshell, the key findings on the role of PGC-1α in mitochondrial dysfunction in HD and its potential as a therapeutic target to cure HD.
Keywords: 3-NP; 3-nitropropionic acid; 4-hydroxynonenal; 8-OHdG; 8-hydroxy-2′-deoxyguanosine; BAT; Energy metabolism; HD; HNE; Huntington's disease; MBP; MDA; Mitochondrial dynamics; Mitochondrial dysfunction; Mitophagy; NOXNADPH; Neurodegeneration; OXPHOS; Oxidative stress; PGC-1α; PPAR; PPARs; ROS; SIRT1; SIRT3; Therapeutics; brown adipose tissue; malondialdehyde; myelin basic protein; oxidase; oxidative phosphorylation; peroxisome proliferator-activated receptor; peroxisome proliferator-activated receptor-γ coactivator-1α; reactive oxygen species.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor γ coactivator 1α expression.J Cell Physiol. 2019 Jun;234(6):9233-9246. doi: 10.1002/jcp.27602. Epub 2018 Oct 26. J Cell Physiol. 2019. PMID: 30362565
-
PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.Prog Neurobiol. 2012 May;97(2):142-51. doi: 10.1016/j.pneurobio.2011.10.004. Epub 2011 Nov 9. Prog Neurobiol. 2012. PMID: 22100502 Free PMC article. Review.
-
Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.Hum Mol Genet. 2010 Aug 15;19(16):3190-205. doi: 10.1093/hmg/ddq229. Epub 2010 Jun 7. Hum Mol Genet. 2010. PMID: 20529956 Free PMC article.
-
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.Cell Metab. 2006 Nov;4(5):349-62. doi: 10.1016/j.cmet.2006.10.004. Epub 2006 Oct 19. Cell Metab. 2006. PMID: 17055784
-
PGC-1alpha, a new therapeutic target in Huntington's disease?Cell. 2006 Nov 3;127(3):465-8. doi: 10.1016/j.cell.2006.10.023. Cell. 2006. PMID: 17081970 Review.
Cited by
-
Mitochondrial biology in airway pathogenesis and the role of NRF2.Arch Pharm Res. 2020 Mar;43(3):297-320. doi: 10.1007/s12272-019-01182-5. Epub 2019 Sep 4. Arch Pharm Res. 2020. PMID: 31486024 Free PMC article. Review.
-
Selective Neuronal Death in Neurodegenerative Diseases: The Ongoing Mystery.Yale J Biol Med. 2019 Dec 20;92(4):695-705. eCollection 2019 Dec. Yale J Biol Med. 2019. PMID: 31866784 Free PMC article. Review.
-
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.Int J Mol Sci. 2023 Aug 21;24(16):13021. doi: 10.3390/ijms241613021. Int J Mol Sci. 2023. PMID: 37629202 Free PMC article. Review.
-
Current and Possible Future Therapeutic Options for Huntington's Disease.J Cent Nerv Syst Dis. 2022 May 21;14:11795735221092517. doi: 10.1177/11795735221092517. eCollection 2022. J Cent Nerv Syst Dis. 2022. PMID: 35615642 Free PMC article. Review.
-
Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.Pharmacol Rev. 2014 Jul;66(3):815-68. doi: 10.1124/pr.113.007757. Pharmacol Rev. 2014. PMID: 24958636 Free PMC article. Review.
References
-
- Group, H.s.D.C.R. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell. 1993;72:971–983. - PubMed
-
- DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA, et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 1995;14:1075–1081. - PubMed
-
- Velier J, Kim M, Schwarz C, Kim TW, Sapp E, Chase K, Aronin N, DiFiglia M. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol. 1998;152:34–40. - PubMed
-
- Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC, Dietrich P, Volvert ML, Guillemot F, Dragatsis I, Bellaiche Y, Saudou F, Nguyen L, Humbert S. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron. 2010;67:392–406. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous